Analysis of apoptotic effects induced by photodynamic therapy in a human biliary cancer cell line

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2113-2118

  Nonaka, Takashi ^a   Nanashima, Atsushi ^a   Nonaka, Mihoko ^a   Uehara, Masataka ^a   Isomoto, Hajime ^a   Asahina, Izumi ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Apoptosis; Cholangiocarcinoma; Local ablation; Photodynamic therapy; Photofrin

Indexed keywords

CASPASE 3; DNA; PHOTOFRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; GALLBLADDER CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT EXPOSURE; MOUSE; NICK END LABELING; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; GALLBLADDER NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955072674     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. McCaughan JS Jr, Mertens BF, Cho C, Barabash RD and Payton HW: Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 126: 111-113, 1991.
2. Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J and Wiedmann M: Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244: 230-239, 2006.
3. Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Muller JM, Hortnagl H and Lochs H: Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114: 536-542, 1998.
4. Berr F, Wiedmann M, Tannapfel A, Halm U, Kohlhaw KR, Schmidt F, Wittekind C, Hauss J and Mossner J: Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31: 291-298, 2000. (Pubitemid 30078590)
5. Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM and de Groen PC: Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53: 500-504, 2001.
6. Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mossner J and Lochs H: Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125: 1355-1363, 2003.
7. Zoepf T, Jakobs R, Arnold JC, Apel D and Riemann JF: Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 100: 2426-2430, 2005. (Pubitemid 43919672)
8. Zoepf T: Photodynamic therapy of cholangiocarcinoma. HPB (Oxford) 10: 161-163, 2008.
9. Dougherty TJ, Gomer C J, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998.
10. Levy JG: Photodynamic therapy. Trends Biotechnol 13: 14-18, 1995.
11. Moore JV, West CM and Whitehurst C: The biology of photodynamic therapy. Phys Med Biol 42: 913-935, 1997.
12. Bressler NM and Bressler SB: Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest Ophthalmol Vis Sci 41: 624-628, 2000. (Pubitemid 30158868)
13. 14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 39: 146-151, 1979.
14. Oleinick NL and Evans HH: The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 150: S146-156, 1998.
15. Ahmad N and Mukhtar H: Mechanism of photodynamic therapy-induced cell death. Methods Enzymol 319: 342-358, 2000. (Pubitemid 30448056)
16. Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T and Nagayasu T: Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol 39: 1095-1101, 2004.
17. Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mossner J, Hauss J and Witzigmann H: Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97: 2783-2790, 2003.
18. Berr F: Photodynamic therapy for cholangiocarcinoma. Semin Liver Dis 24: 177-187, 2004.
19. Zoepf T, Jakobs R, Arnold J C, Apel D, Rosenbaum A and Riemann JF: Photodynamic therapy for palliation of nonresectable bile duct cancer - preliminary results with a new diode laser system. Am J Gastroenterol 96: 2093-2097, 2001.
20. Dumoulin FL, Gerhardt T, Fuchs S, Scheurlen C, Neubrand M, Layer G and Sauerbruch T: Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 57: 860-867, 2003.
21. Kessel D, Luo Y, Deng Y and Chang CK: The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem Photobiol 65: 422-426, 1997. (Pubitemid 27158974)
22. Granville DJ, Shaw JR, Leong S, Carthy CM, Margaron P, Hunt DW and McManus BM: Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. Am J Pathol 155: 1021-1025, 1999.
23. Granville DJ, Carthy C M, Jiang H, Levy JG, McManus BM, Matroule JY, Piette J and Hunt D W: Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood 95: 256-262, 2000.
24. Carthy CM, Granville DJ, Jiang H, Levy JG, Rudin CM, Thompson CB, McManus BM and Hunt DW: Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab Invest 79: 953-965, 1999.
25. Noodt BB, Berg K, Stokke T, Peng Q and Nesland JM: Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer 74: 22-29, 1996. (Pubitemid 26231973)
26. Chan WS, Brasseur N, La Madeleine C and van Lier JE: Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Anticancer Res 16: 1887-1892, 1996.
27. van Geel IP, Oppelaar H, Oussoren YG and Stewart FA: Changes in perfusion of mouse tumours after photodynamic therapy. Int J Cancer 56: 224-228, 1994. (Pubitemid 24076123)
28. Riva C, Chauvin C, Pison C and Leverve X: Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res 18: 4729-4736, 1998. (Pubitemid 29042052)
29. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch C J, Ratcliffe P, Moons L, Jain RK, Collen D and Keshert E: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998.
30. Araya R, Uehara T and Nomura Y: Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett 439: 168-172, 1998.